@article{w.y. chay2018bevacizumab,
  title={Single-agent bevacizumab for the management of refractory malignant effusions in heavily pretreated patients with recurrent high-grade serous cancers of the ovary, fallopian tube or peritoneum: results from a single institution},
  author={w.y. chay,a. kumar,p.j. hoskins,a.v.tinke},
  journal={European Journal of Gynaecological Oncology},
  volume={39},
  number={6},
  pages={887--880},
  doi = {10.12892/ejgo4452.2018},
  year={2018}
}